Lv3
284 积分 2022-09-05 加入
Advances in targeted and cellular therapies for relapsed/refractory mantle cell lymphoma: immunotherapeutic strategies and challenges
2个月前
已完结
Combined PET and ctDNA response as a predictor of POD24 for follicular lymphoma after first-line induction treatment
3个月前
已完结
Clinical features and prognostic factors of primary gastrointestinal lymphoma
3个月前
已关闭
Molecular Features of Response and Resistance to Glofitamab, a T-Cell Engager for treatment of Large B-Cell Lymphoma
5个月前
已关闭
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab
6个月前
已完结
Chimeric antigen receptor T-cell therapy and bispecific antibody sequence for large B-cell lymphoma: a systematic review and meta-analysis
7个月前
已完结
Treatment of relapsed and refractory follicular lymphoma: which treatment for which patient for which line of therapy?
8个月前
已完结
Building the future management of follicular lymphoma with T-cell–redirecting strategies
8个月前
已完结
Frontline treatment of follicular lymphoma: What will it take to change current practice?
8个月前
已完结
The future of follicular lymphoma management: strategies on the horizon
8个月前
已完结
皖公网安备34019202002308
